• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail

Refusal Actions by FDA as Recorded in OASIS

for 60-Human and Animal Drugs

Entry/doc/line/sfx Refusal Date Product
FP1-0008186-7/15/1 12-Oct-2012 60CCK04 3003569806 Meda Pharma Gmbh & Co. KG Germany
FP1-0008186-7/16/1 12-Oct-2012 60CCK04 3000191104 Owen Mumford, Ltd. United Kingdom
UPS-7300335-8/1/1 30-Oct-2012 60CDY10 3002558729 Productos Medix Sa De Cv Mexico
FY4-0078281-6/5/1 04-Oct-2012 60DAJ02 3006680975 China Ningbo International Corporation Co.,Ltd. China
U72-0519296-7/32/1 29-Oct-2012 60FBZ03 3009661949 Pz Cussons Nig Plc Nigeria
FP1-0008186-7/5/1 12-Oct-2012 60LAK14 3009516425 Taro Pharmaceuticals Ltd United Kingdom
XXX-0262480-8/1/10 15-Oct-2012 60LAY05 3008029840 Bayer S.A. Guatemala
XXX-0244287-0/1/16 09-Oct-2012 60LCY05 3006785729 Laboratorio Winthrop Colombia
XXX-0191878-9/1/1 05-Oct-2012 60LDY99 3005541483 Laboratorios Piersan S. A. Guatemala
112-9474276-7/1/1 05-Oct-2012 60LIA99 1000601967 Nippon Zoki Japan
AG0-0138713-7/1/1 17-Oct-2012 60LPO99 3003218284 Kyron Laboratories South Africa
112-9553959-2/1/1 11-Oct-2012 60QDR41 3009053501 Jinan Chenghui-Shuangda Chemical China
UPS-8078506-2/1/1 30-Oct-2012 60RCE18 3009777527 Hilda Campos Charry Colombia
G08-0028619-0/13/2/E 16-Oct-2012 60RCH18 3003716872 Roche S.p.A. Italy
XXX-0262480-8/1/3 15-Oct-2012 60RCY18 3003948827 Laboratorios Liomont, S.A. de C.V. Mexico
D21-0054365-3/3/1 29-Oct-2012 60SAA99 3006313379 Ad Channel India
D21-0054298-6/13/1 09-Oct-2012 60SAZ99 3007313144 Capital Ventures India
FP1-0008186-7/22/1 12-Oct-2012 60WCA16 3003164454 Janssen - Cilag Spa. Italy